COVID-19 Prevention
Sort by:
HIV Center for Clinical and Behavioral Studies
HIV and COVID-19 Public Health Responses: Lessons Learned From Each to Inform the Other
FEATURING
David Holtgrave
- 159 views
- February 23, 2022
Columbia University's Zuckerman Institute
Neutralizing Antibodies Against Pandemic Viruses
FEATURING
Pamela J. Bjorkman
- 93 views
- February 16, 2022
- 3
Columbia University's Zuckerman Institute
Tracking SARS-CoV-2 Variants in the UK
FEATURING
Emma Thomson
- 16 views
- April 19, 2022
Columbia University's Zuckerman Institute
Exosomal ACE2 Neutralizes Broad Variants of SARS-CoV-2
FEATURING
Lamiaa El-Shennawy
- 7 views
- April 19, 2022
Amesh Adalja
Are COVID-19 Vaccine Boosters Necessary for the General Population Right Now?
- 8,440 views
- September 17, 2021
- 114
MIT Department of Biology
Innate Imbalance and Suboptimal COVID-19 Immunity
FEATURING
Shiv Pillai
- 150 views
- January 11, 2022
- 3
Francesca Torriani
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
- 10,173 views
- September 16, 2021
- 28
Monica Gandhi
PPE in the Post COVID-19 World: Is Universal Masking the New Standard?
- 2,000 views
- October 25, 2021
- 13
MedCram
COVID-19 Vaccine Efficacy Versus Delta Variant: Real World Data
FEATURING
Roger Seheult
- 5,495 views
- September 24, 2021
- 31
UCSF School of Medicine
COVID-19 - Lessons Learned & What’s Ahead: A Conversation With Dr. Ashish Jha
FEATURING
Robert Wachter,
Ashish Jha
- 2,239 views
- October 19, 2021
- 21
UCSF School of Medicine
Oral Antivirals for COVID-19: How Do They Work? When to Use Monoclonal Antibodies Versus the New Antivirals?
FEATURING
Annie Luetkemeyer
- 290 views
- December 7, 2021
- 4
MIT Department of Biology
Broadly Neutralizing Antibodies to Speed Pandemic Responses
FEATURING
Laura Walker
- 79 views
- January 11, 2022
- 3
MedCram
COVID-19 Vaccine Myths With MedCram: Delta Transmission Prevention and T-Cell Immunity
FEATURING
Roger Seheult,
Rhonda Patrick
- 2,025 views
- October 5, 2021
- 14
MedCram
Omicron Versus Delta: Infection Rates and Natural Immunity
FEATURING
Roger Seheult
- 160 views
- December 7, 2021
- 1
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference
Platform Studies in COVID-19
FEATURING
Larry Tsai
- 72 views
- January 12, 2022
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference
Q&A: COVID-19 Lung Complications
- 25 views
- January 12, 2022
Columbia University's Zuckerman Institute
Antiviral Strategy for SARS-CoV-2: Lethal Mutagenesis With Molnupiravir/NHC
FEATURING
Ronald Swanstrom
- 198 views
- November 19, 2021
- 2
The Ludeman Family Center for Women’s Health Research
COVID-19 and the ISMS: Effects on Communities, Practices, and Patients
FEATURING
Andrea Nederveld
- 73 views
- January 7, 2022
MIT Department of Biology
Public Health at Work: CDC and the COVID-19 Response
FEATURING
Rochelle Wolensky
- 25 views
- January 11, 2022